Transcriptional control in innate lymphoid type II cells
先天淋巴细胞 II 型细胞的转录控制
基本信息
- 批准号:8732115
- 负责人:
- 金额:$ 23.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-01 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdoptive TransferAmphiregulinApplications GrantsAsthmaBehaviorBiologyBone MarrowBystander EffectCell physiologyCellsChimera organismDataDevelopmentDiseaseDown-RegulationEffectivenessEpidermal Growth FactorEpithelialExcisionExhibitsFutureGene ExpressionGenerationsGenetic ProgrammingHealthHomeostasisHypersensitivityImmuneImmune responseImmune systemImmunocompetentImmunosuppressive AgentsIn VitroInflammationInflammatoryInfluenzaInterleukin-13Interleukin-17Interleukin-5Internal Ribosome Entry SiteLungLung InflammationLymphoidLymphoid CellMaintenanceMediatingMesenteryNeutrophil InfiltrationPapainPathologyPatientsPeripheralPlayPneumoniaPopulationProductionRag1 MouseRiskRoleStructure of parenchyma of lungSystemT-LymphocyteTestingTherapeuticTissuesTranscription factor genesTranscriptional RegulationType II Epithelial Receptor CellUp-RegulationVirus Diseasesairway inflammationairway remodelingcell typecytokineeosinophilin vivointerleukin-22lymph nodesmouse modelprogramspublic health relevanceresearch studyresponsetherapeutic targettherapy developmenttissue repairtranscription factor
项目摘要
DESCRIPTION (provided by applicant): Recent evidence shows that innate lymphoid type 2 cells (ILC2s) through production of IL-13 and IL-5 are critical in airway pathologies and tissue damage, strongly correlated with severe asthma. ILC2s not only produce IL-5 and IL-13, but also the epidermal growth factor amphiregulin, which promotes tissue remodeling and lung homeostasis following influenza infection. For developing therapeutic strategies to specifically target ILC2-mediated inflammation, while maintaining tissue repair activity, it is of crucial importance to delineate regulatory mechanisms involved in ILC2 development, maintenance and function. Our preliminary data demonstrate that Bcl11b is highly expressed in ILC2 cells in the periphery, as well as in bone marrow precursors. Induced removal of Bcl11b causes loss of their identity. Bcl11b-/- ILC2 population showed reduced IL-5 production following papain-induced lung inflammation, resulting in diminished eosinophil and increased neutrophil recruitment to the lung. Additionally, numbers of ILC2s were overall reduced in the bone marrow. In this grant application we propose to establish the role of Bcl11b in ILC2s lineage determination, in mature ILC2 cell function and identity and determine the mechanisms by which Bcl11b controls ILC2 genetic program.
描述(由申请人提供):最近的证据表明,通过产生IL-13和IL-5的先天淋巴2型细胞(ILC 2)在气道病理和组织损伤中至关重要,与重度哮喘密切相关。ILC 2不仅产生IL-5和IL-13,而且还产生表皮生长因子双调蛋白,其促进流感感染后的组织重塑和肺内稳态。为了开发特异性靶向ILC 2介导的炎症的治疗策略,同时维持组织修复活性,描述参与ILC 2发育、维持和功能的调控机制至关重要。我们的初步数据表明,Bcl 11b是高度表达的ILC 2细胞在周边,以及在骨髓前体。诱导Bcl 11b的去除导致其身份的丧失。Bcl 11b-/-ILC 2群体在木瓜蛋白酶诱导的肺部炎症后显示IL-5产生减少,导致嗜酸性粒细胞减少和中性粒细胞向肺的募集增加。此外,骨髓中ILC 2的数量总体上减少。在本申请中,我们建议确定Bcl 11b在ILC 2谱系确定、成熟ILC 2细胞功能和身份中的作用,并确定Bcl 11b控制ILC 2遗传程序的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dorina Avram其他文献
Dorina Avram的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dorina Avram', 18)}}的其他基金
Tissue-Anchored vs. Circulating Engineered Enzyme Constructs for Immunometabolic Resolution of Psoriasis
组织锚定与循环工程酶构建体用于银屑病免疫代谢解决
- 批准号:
10667165 - 财政年份:2023
- 资助金额:
$ 23.7万 - 项目类别:
High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosis
高通量筛选分析,鉴定针对 Hectd3 的化学探针,Hectd3 是一种与多发性硬化症有关的 E3 泛素连接酶
- 批准号:
10391539 - 财政年份:2021
- 资助金额:
$ 23.7万 - 项目类别:
High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosis
高通量筛选分析,鉴定针对 Hectd3 的化学探针,Hectd3 是一种与多发性硬化症有关的 E3 泛素连接酶
- 批准号:
10597043 - 财政年份:2021
- 资助金额:
$ 23.7万 - 项目类别:
Tolerogenic dual microparticle system for treatment of multiple sclerosis
用于治疗多发性硬化症的致耐受性双微粒系统
- 批准号:
9918870 - 财政年份:2017
- 资助金额:
$ 23.7万 - 项目类别:
Transcriptional control in innate lymphoid type II cells
先天淋巴细胞 II 型细胞的转录控制
- 批准号:
8853814 - 财政年份:2014
- 资助金额:
$ 23.7万 - 项目类别:
Regulation of CD4 T cell Development and Function by BCL11B Transcription Factor
BCL11B 转录因子对 CD4 T 细胞发育和功能的调节
- 批准号:
8021853 - 财政年份:2008
- 资助金额:
$ 23.7万 - 项目类别:
Regulation of CD4 T cell Development and Function by BCL11B Transcription Factor
BCL11B 转录因子对 CD4 T 细胞发育和功能的调节
- 批准号:
7760538 - 财政年份:2008
- 资助金额:
$ 23.7万 - 项目类别:
Regulation of CD4 T cell Development and Function by BCL11B Transcription Factor
BCL11B 转录因子对 CD4 T 细胞发育和功能的调节
- 批准号:
7437569 - 财政年份:2008
- 资助金额:
$ 23.7万 - 项目类别:
Regulation of CD4 T cell Development and Function by BCL11B Transcription Factor
BCL11B 转录因子对 CD4 T 细胞发育和功能的调节
- 批准号:
8213720 - 财政年份:2008
- 资助金额:
$ 23.7万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 23.7万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 23.7万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 23.7万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 23.7万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 23.7万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 23.7万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 23.7万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 23.7万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 23.7万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 23.7万 - 项目类别: